Market Tracker

10/31 10:00pm ET

Redhill Biopharma Ltd (NASDAQ:RDHL)

9.24
Data as of 3:07pm ET
 -0.0766 / -0.82%
Today’s Change
8.37
Today|||52-Week Range
21.00
-21.67%
Year-to-Date
No recent news for Redhill Biopharma Ltd.

Today’s Trading

Previous close9.32
Today’s open9.32
Day’s range9.20 - 9.32
Volume2,003
Average volume (3 months)6,086
Market cap$81.9M
Dividend yield--
Data as of 3:07pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)+14.73%
Earnings growth (this year)+31.76%
Earnings growth (next 5 years)--
Revenue growth (last year)-24.76%
P/E ratio--
Price/Sales6,117.05
Price/Book6.83

Competitors

 Today’s
change
Today’s
% change
DRRXDURECT Corp-0.01-1.35%
NERVMinerva Neuroscience...+0.02+0.46%
BOTABiota Pharmaceutical...+0.05+2.08%
IMMYImprimis Pharmaceuti...-0.11-1.26%
Data as of 3:59pm ET, 10/31/2014

Financials

Next reporting dateNovember 11, 2014
EPS forecast (this quarter)-$0.50
Annual revenue (last year)$12.0K
Annual profit (last year)-$10.7M
Net profit margin-88,566.67%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Dror Ben-Asher
Director, Deputy CEO-Finance &
Operations
Ori Shilo
Corporate headquarters
Tel Aviv, --

Forecasts